C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2004
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487792A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
12/22/2004	EP1487785A2 Novel florfenicol-type antibiotics
12/22/2004	EP1487446A2 Bicyclic heterocycles for the treatment of diabetes and other diseases
12/22/2004	EP1487443A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
12/22/2004	EP1487442A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists
12/22/2004	EP1086076B1 Sulfonamide inhibitors of aspartyl protease
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556803A New organic compounds for electroluminescence and oganic electroluminescent devices using the same
12/22/2004	CN1556797A Substituted isoxazole compound and its application as antibiotics
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1181069C Novel inhibitors of farnesyl-protein transferase
12/21/2004	US6833387 Chemical compounds
12/21/2004	US6833380 Compounds that modulate PPAR activity and methods of preparation
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/21/2004	US6833369 Treatment of ocular neovascular diseases, neovascular glaucoma, diabetic retinopathy,
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/16/2004	WO2004108721A1 Process for the preparation of 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl] methyl]-2,4-thiazolidinedione
12/16/2004	WO2004108720A1 7- (1, 3-thiazol-2-yl)thio!-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
12/16/2004	WO2004108705A1 3-fluoro-piperidines as nmda/nr2b antagonists
12/16/2004	WO2004108695A1 Anti-leishmania agent
12/16/2004	WO2004108694A1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
12/16/2004	WO2004108692A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108686A2 Benzimidazole compounds having hypoglycemic activity
12/16/2004	WO2004108685A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	WO2004108672A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	WO2004108661A1 Amidino compounds as cysteine protease inhibitors
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004085433A3 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/16/2004	WO2004037789A8 Methylene urea derivatives as raf-kinase inhibitors
12/16/2004	WO2003090539A8 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
12/16/2004	WO2002076177A3 Design and synthesis of optimized ligands for ppar
12/16/2004	US20040254380 NK-1 receptor antagonists
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254373 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/16/2004	US20040254370 Peroxisome proliferators activated receptor regulator; useful for hypoglycemia, hypolipidemia, preventing and/or treatment of diseases associating metabolic disorders, atherosclerosis, cardiovascular diseases, syndrome x, cholestrol
12/16/2004	US20040254236 Antiinflammatory agents; moderate cytokine activity; bone disorders autoimmune disease; neurodegenerative diseases; viricides; asthma; antiallergens; adult respiratory distress syndrome; antiarthritic agents; antidiabetic agents
12/16/2004	US20040254220 Histone deacetylase inhibitors
12/16/2004	US20040254213 Use of bicyclo compounds for treating alzheimer's disease
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004	US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants
12/16/2004	US20040254180 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
12/16/2004	US20040254179 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254175 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents
12/16/2004	US20040254160 Benzothiazepine derivatives
12/16/2004	US20040254159 Antiproliferative agents
12/16/2004	US20040253697 Nucleotide sequences coding epothilone polyketide synthase for use in generating fungicides, immunosuppressants and/or antitumor agents in microorganisms; bioreactors and heterologous gene expression
12/16/2004	US20040253182 Pathological tissue detection and treatment employing targeted benzoindole optical agents
12/16/2004	DE10323970A1 Neue Thiazolylmethyl-pyrazole, Verfahren zu deren Herstellung sowie deren Verwendung in Färbemitteln für Keratinfasern New thiazolylmethyl-pyrazoles, to processes for their preparation and their use in colorants for keratin fibers
12/16/2004	CA2528093A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	CA2527769A1 7- (1, 3-thiazol-2-yl)thio!-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
12/16/2004	CA2526694A1 Amidino compounds as cysteine protease inhibitors
12/16/2004	CA2525093A1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
12/15/2004	EP1486549A1 Organic electroluminescent element
12/15/2004	EP1486494A1 N-substituted benzothiophenesulfonamide derivative
12/15/2004	EP1486490A1 Azole compounds
12/15/2004	EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004	EP1485376A1 Compositions useful as inhibitors of protein kinases
12/15/2004	EP1485371A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/15/2004	EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485167A1 1,2-dihydropyrazol-3-ones as cytokine mediators
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/15/2004	EP1485091A1 Thiazole and oxazole derivatives that modulate ppar activity
12/15/2004	EP1484971A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
12/15/2004	EP1284267B1 Triazole compounds having amide linkage
12/15/2004	EP1218005B1 Vitronectin receptor antagonists
12/15/2004	CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004	CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004	CN1555259A use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179945C Indole derivatives, process for preparation of same and use thereof
12/15/2004	CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004	US6831090 Having microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tunior cells or other hyperproliferative cellular disease
12/14/2004	US6831076 Epothilons C and D, preparation and compositions
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	CA2136075C Heterocyclic ether compounds that enhance cognitive function
12/09/2004	WO2004106332A1 Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers
12/09/2004	WO2004106323A1 Method for producing cyclic diamine derivative or salt thereof
12/09/2004	WO2004106317A1 Benzofuran compound and medicinal composition containing the same
12/09/2004	WO2004106305A1 New p2x7 receptor antagonists and their use
12/09/2004	WO2004106304A2 3 - [2- (3-amino-2-oxo-2h-pyridin-1-yl) - acetylamino] - 4- oxo-pentanoic acid derivatives and their use as caspase inhibitors
12/09/2004	WO2004105755A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
12/09/2004	WO2004105752A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors

1 ... 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 ... 628